BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Enterprise value to EBITDA ratio
3Y CAGR
-36.6%/yr
Annual compound
5Y CAGR
-37.4%/yr
Consistent
Percentile
P50
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
4 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 18.73 | -0.1% |
| 2024 | 18.75 | -68.8% |
| 2023 | 60.15 | -18.3% |
| 2022 | 73.64 | -79.0% |
| 2021 | 351.17 | +80.3% |
| 2020 | 194.76 | -60.0% |
| 2019 | 487.47 | +110.7% |
| 2018 | -4573.64 | -2679.4% |
| 2017 | 177.32 | +982.5% |
| 2016 | -20.09 | - |